Literature DB >> 24554819

Pure Erythroleukemia (Variant Acute Myeloid Leukemia-vAML-M6) with Deletion of Chromosome 20, Mainly Presenting as Late Erythroblasts, a Unique Case Report with Review of Literature.

Javid Rasool1, Sajad Geelani1, Mohd Suhail Lone1, Mohd Shaban1.   

Abstract

Acute erythroleukemia is characterized by a predominant immature erythroid population and accounts for approximately 2-5 % of all cases of acute leukemia. Two subtypes are recognized based on the presence or absence of a significant myeloid component: erythroleukemia and pure erythroid leukemia. Erythroleukemia is predominantly a disease of adults, while pure erythroid leukemia can be seen in any age including children. Here is a case of pure erythroleukemia presenting mainly as late erythroblasts which was diagnosed on bone marrow examination, cytochemistry and was confirmed on immunophenotyping. Possibly this is the only case so for demonstrating deletion of long arm of chromosome 20 in pure erythroleukemia.

Entities:  

Keywords:  Deletion 20q; Late erythroblasts; Pure erythroleukemia

Year:  2012        PMID: 24554819      PMCID: PMC3921337          DOI: 10.1007/s12288-012-0180-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  17 in total

1.  The expression of human blood group antigens during erythropoiesis in a cell culture system.

Authors:  M J Southcott; M J Tanner; D J Anstee
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

2.  Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6.

Authors:  F M Mazzella; H R Schumacher
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

3.  Acute erythroleukemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis.

Authors:  F M Mazzella; A Kowal-Vern; M A Shrit; A L Wibowo; J T Rector; J D Cotelingam; J Collier; A Mikhael; H Cualing; H R Schumacher
Journal:  Am J Clin Pathol       Date:  1998-11       Impact factor: 2.493

4.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

5.  Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types.

Authors:  A Cuneo; A Van Orshoven; J L Michaux; M Boogaerts; A Louwagie; C Doyen; P Dal Cin; F Fagioli; G Castoldi; H Van den Berghe
Journal:  Br J Haematol       Date:  1990-07       Impact factor: 6.998

6.  The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.

Authors:  S L Goldberg; P Noel; T R Klumpp; G W Dewald
Journal:  Am J Clin Oncol       Date:  1998-02       Impact factor: 2.339

7.  The prognostic significance of proerythroblasts in acute erythroleukemia.

Authors:  A Kowal-Vern; J Cotelingam; H R Schumacher
Journal:  Am J Clin Pathol       Date:  1992-07       Impact factor: 2.493

8.  A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties.

Authors:  K Wheatley; A K Burnett; A H Goldstone; R G Gray; I M Hann; C J Harrison; J K Rees; R F Stevens; H Walker
Journal:  Br J Haematol       Date:  1999-10       Impact factor: 6.998

9.  The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.

Authors:  P D Kottaridis; R E Gale; M E Frew; G Harrison; S E Langabeer; A A Belton; H Walker; K Wheatley; D T Bowen; A K Burnett; A H Goldstone; D C Linch
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

10.  Minimally differentiated erythroleukaemia (AML M6 'variant'): a rare subset of AML distinct from AML M6. Groupe Français d'Hématologie Cellulaire.

Authors:  R Garand; E Duchayne; D Blanchard; N Robillard; E Kuhlein; O Fenneteau; F Salomon-Nguyen; M J Grange; P Rousselot; C Demur
Journal:  Br J Haematol       Date:  1995-08       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.